Previous Close | 44.55 |
Open | 44.70 |
Bid | 45.70 x 0 |
Ask | 45.95 x 0 |
Day's Range | 44.70 - 46.25 |
52 Week Range | 14.44 - 50.80 |
Volume | |
Avg. Volume | 90,159 |
Market Cap | 3.007B |
Beta (5Y Monthly) | 0.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -6.22 |
Earnings Date | Feb 20, 2025 - Feb 24, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 90.00 |
As global markets show resilience with major U.S. indexes approaching record highs and smaller-cap indexes outperforming, investor sentiment remains cautiously optimistic amid geopolitical tensions and economic uncertainties. In this environment, identifying high-growth tech stocks requires a focus on companies that demonstrate strong fundamentals, innovative capabilities, and adaptability to evolving market conditions.
LUND, SWEDEN / ACCESSWIRE / October 31, 2024 / BioInvent International (STO:BINV) "Progress to date brings the company one step closer to addressing the needs for new treatment solutions for patients. As part of our Q3 report, we are today pleased ...